Skip to main content
SpringerLink
Log in

CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules

  • Research Article
  • Published:
Tumor Biology

Abstract

CDX-2 is a caudal-type homeobox gene, encoding a transcription factor that plays an important role in proliferation and differentiation of intestinal epithelial cells. The utility of antibodies to CDX2 in the identification of adenocarcinomas of the gastrointestinal tract, particularly colorectal adenocarcinomas, in both primary and metastatic settings is well established. It is well-known that patients with testicular tumors may occasionally lack an obvious palpable mass. However, the expression of CDX2 in malignant germ cell tumors of the testes which have metastatic potential has not been previously studied in a large series. A tissue microarray was constructed from 52 malignant germ cell tumors of the testes including: 29 cases of classic seminoma, 8 cases of embryonal carcinoma, 8 cases of yolk sac tumor, 4 cases of malignant teratoma, 2 cases of choriocarcinoma, and 1 case of spermatocytic seminoma. Ten cases of intratubular germ cell neoplasia and seven cases of benign testicles with normal seminiferous tubules were also included in tissue microarray. Immunohistochemical stains for CDX2 was performed and analyzed. Only nuclear staining was considered positive. Positive expression of CDX2 was identified in 2/2 cases (100 %) of choriocarcinoma, 4/8 cases (50 %) of teratoma, 3/8 cases (38 %) of embryonal carcinoma, 3/8 cases (38 %) of yolk sac tumor, and 1/29 cases (3 %) of classic seminoma. CDX2 was negative in all cases of intratubular germ cell neoplasia, normal seminiferous tubules, and the only case of spermatocytic seminoma. The role of CDX-2 in the differentiation of intestinal/enteric epithelial cells may contribute to the formation of trophoblastic, glandular, villous, or cystic structures in germ cell tumors of the testes. This study suggests that the expression of CDX2 in a variety of malignant germ cell tumors of the testes may be a potential pitfall in metastatic tumors of unknown primary, which are thought to be of gastrointestinal/colorectal origin but are actually from a clinically occult testicular tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Stainier DY. No organ left behind: tales of gut development and evolution. Science. 2005;307(5717):1902–4.

    Article  PubMed  CAS  Google Scholar 

  2. Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. 1996;16(2):619–25.

    PubMed  CAS  Google Scholar 

  3. Fraggetta F, Pelosi G, Cafici A, et al. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch. 2003;443(6):782–6.

    Article  PubMed  CAS  Google Scholar 

  4. Houghton O, Connolly LE, McCluggage WG. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology. 2008;53(2):156–65.

    Article  PubMed  CAS  Google Scholar 

  5. Wani Y, Notohara K, Saegusa M, Tsukayama C. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Hum Pathol. 2008;39(7):1072–9.

    Article  PubMed  CAS  Google Scholar 

  6. Jaffee IM, Rahmani M, Singhal MG, Younes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med. 2006;130(10):1522–6.

    PubMed  Google Scholar 

  7. Sullivan LM, Smolkin ME, Frierson Jr HF, Galgano MT. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. Am J Surg Pathol. 2008;32(11):1608–12.

    Article  PubMed  Google Scholar 

  8. Herawi M, De Marzo AM, Kristiansen G, Epstein JI. Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. Hum Pathol. 2007;38(1):72–8.

    Article  PubMed  CAS  Google Scholar 

  9. Devesa SS, Blot WJ, Stone BJ, et al. Recent cancer trends in the United States. J Natl Cancer Inst. 1995;87(3):175–82.

    Article  PubMed  CAS  Google Scholar 

  10. Wu X, Groves FD, McLaughlin CC, et al. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control. 2005;16(3):309–20.

    Article  PubMed  Google Scholar 

  11. Talerman A. Germ cell tumours. Ann Pathol. 1985;5(3):145–57.

    PubMed  CAS  Google Scholar 

  12. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88(11):727–33.

    Article  PubMed  CAS  Google Scholar 

  13. Zheng T, Holford TR, Ma Z, et al. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int J Cancer. 1996;65(6):723–9.

    Article  PubMed  CAS  Google Scholar 

  14. Ye H, Ulbright TM. Difficult differential diagnoses in testicular pathology. Arch Pathol Lab Med. 2012;136(4):435–46.

    Article  PubMed  Google Scholar 

  15. Ulbright TM, Young RH, Scully RE. Trophoblastic tumors of the testis other than classic choriocarcinoma: “monophasic” choriocarcinoma and placental site trophoblastic tumor: a report of two cases. Am J Surg Pathol. 1997;21(3):282–8.

    Article  PubMed  CAS  Google Scholar 

  16. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79.

    Article  PubMed  Google Scholar 

  17. Kao CS, Idrees MT, Young RH, Ulbright TM. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases. Am J Surg Pathol. 2012;36(3):360–7.

    Article  PubMed  Google Scholar 

  18. Bing Z, Pasha T, Tomaszewski JE, Zhang P. CDX2 expression in yolk sac component of testicular germ cell tumors. Int J Surg Pathol. 2009;17(5):373–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Emory University School of Medicine, Room H174, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA

    Michael J. Lee, Adam P. Vogt & Adeboye O. Osunkoya

  2. Department of Urology, Emory University School of Medicine, Atlanta, GA, USA

    Wayland Hsiao & Adeboye O. Osunkoya

  3. Emory Winship Cancer Institute, Atlanta, GA, USA

    Adeboye O. Osunkoya

Authors
  1. Michael J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam P. Vogt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wayland Hsiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adeboye O. Osunkoya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adeboye O. Osunkoya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, M.J., Vogt, A.P., Hsiao, W. et al. CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules. Tumor Biol. 33, 2185–2188 (2012). https://doi.org/10.1007/s13277-012-0479-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-012-0479-z

Keywords

Search

Navigation